Jump to content
  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type

Product Groups

  • Memberships
  • Merchandise
  • Legacy Products

Forums

  • General Info
    • Question of the Day
    • Introductions
    • Job Postings
    • Off Topic
    • Site Comments / Suggestions
  • BloodBankTalk (USA)
    • Transfusion Services
    • Patient Questions
    • Accrediting Agencies
    • Billing
    • Case Studies
    • Computer Systems / Software / ISBT128
    • Donor Services and Donor Recruitment
    • Education / Quality
    • Equipment
    • Immunohematology Reference Laboratories
    • Tissue, stem cells, and bone marrow
    • Vendor Section
    • All other topics
  • BloodBankTalk (United Kingdom)
    • Haemovigilance
    • Quality
    • UK Guidelines
  • ChemLabTalk
    • General Information
    • Equipment
    • Accrediting Agencies
  • HemeLabTalk
    • General Information
    • Accrediting Agencies
  • MicroLabTalk
    • General Information
    • Quality
  • POCTalk
    • General Information
    • Accrediting Agencies
    • Vendor Selection

Blogs

  • PathLabTalk News
  • Laboratory News

Calendars

  • Community Calendar

Categories

There are no results to display.

Categories

There are no results to display.

Categories

  • PathLabTalk Information
  • Posting
  • Member Information
  • How to...
  • Library
  • Jobs
  • Advertisers

Categories

  • User Submitted
    • Audit checklists
    • Direct Observation Checklists
    • Educational Materials
    • Forms
    • SOPs
  • United States
    • FDA Blood Guidances
    • FDA Memorandum to Blood Establishments
  • Canada
    • Health Canada

Categories

  • Lab Assistants
  • Medical Laboratory Scientists
  • Research
  • Nursing

Categories

  • Records

Find results in

Find results that contain...

Date Created

  • Start

    End

Last Updated

  • Start

    End


Filter by number of...

Found 2 results

  1. For those of you treating cells with DTT for patients taking daratumumab/darzalex: Have you come across a positive autocontrol, with treated and untreated cells? Currently, patient on DARA: initial screen-panagglutinin, auto-positive. Testing with treated cells: screen-negative, auto-positive. QC-valid (testing Kpos and Epos cell) antigen typing for K-neg, E-pos I have been unable to find any research with this information. We are currently in the process of validating DTT treatment. Any advice would be welcomed. Thank you
  2. Are antibody screens required at delivery in obstetrics patients who had a negative antibody screen at 28 weeks? When RhIG is administered at 28 weeks, all screens are positive in our experience. We do not have an option for a mini-screen using solid phase. At least one obstetrician wants all of these extensively worked up, "in case the RhIG did not work". Thank you in advance for taking your time to comment.

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.